Find clinical trials for Breast Cancer in London, England
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Breast Cancer trials near London, England, GBR:
There is growing evidence that cancer DNA (called circulating tumour DNA - ctDNA) in the blood is often an early sign that the cancer...
Phase 2
London, United Kingdom
The purpose of this study is to find out how effective the combination of crizotinib and fulvestrant is in shrinking lobular breast cancer...
Phase 2
London, United Kingdom and 4 other locations
This prospective, multicenter, 1:1 randomized, controlled trial is designed to evaluate the safety and effectiveness of the Breast Cancer...
London, United Kingdom and 25 other locations
adjuvant systemic treatment instead of adjuvant chemotherapy followed by endocrine therapy in older patients with stage II-III ER+/HER2- early breast...
Phase 2
London, United Kingdom and 72 other locations
This neoadjuvant trial for patients with TNBC and/or gBRCA breast cancer, aims to investigate the safety and efficacy (improvement ...
Phase 2, Phase 3
London, United Kingdom and 29 other locations
be investigating how effective the combination is for a subgroup of breast cancer patients whose cancer expresses the andr...
Phase 1
London, United Kingdom and 6 other locations
This study will be conducted in patients with metastatic breast cancer who have specific Fibroblast Growth Factor Receptor gene abn...
Phase 2
London, England, United Kingdom and 36 other locations
DESTINY-Breast07 will investigate the safety, tolerability, and anti-tumour activity of trastuzumab deruxtecan (T-DXd) in combination with o ...
Phase 1, Phase 2
Buckhurst Hill, United Kingdom and 71 other locations
The aim of this study is to assess the rates of circulating tumour DNA (ctDNA) in patients treated with surgery for stage 1 breast cancer...
London, United Kingdom and 1 other location
A Phase 1 Dose Escalation and Expansion Study of AZD9833 Alone or in Combination in Women with ER Positive, HER2 Negative Advanced Breast Ca...
Phase 1
London, United Kingdom and 16 other locations
Clinical trials
Research sites
Resources
Legal